Studies with (+) octanoylcarnitine in experimental diabetic ketoacidosis

J. D. McGarry, D. W. Foster

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The ability of (+) decanoylcarnitine to inhibit ketogenesis in perfused livers from severely ketotic alloxan diabetic rats and to cause the rapid reversal of ketoacidosis in intact animals was shown not to be the result of a detergent action of this compound, since no such effects were seen when similar experiments were carried out with (-) decanoylcarnitine. Comparison of the hexanoyl, octanoyl and decanoyl esters of (+) carnitine for their antiketogenic capacity in perfused livers from alloxan diabetic rats revealed that the 8 and 10 carbon homologues were equally effective, with the 6 carbon species having less inhibitory properties. When tested in vivo, both in the presence and absence of insulin, the 8 carbon species exhibited the greatest hypoketonemic potential. Further studies with (+) octanoylcarnitine showed that its potent effects in the rat are completely reversible; it is not metabolized in this animal species and is rapidly excreted by the kidneys; it has a far lower hemolytic capacity than (+) decanoylcarnitine; and it is capable of reversing severe ketoacidosis when administered orally, although the doses required using this procedure are much greater than those needed when the agent is given intravenously. It is concluded that (+) acylcarnitines are useful tools for studies of metabolic regulation both in vitro and in vivo. In this regard the compound of choice would seem to be (+) octanoylcarnitine.

Original languageEnglish (US)
Pages (from-to)485-493
Number of pages9
JournalDiabetes
Volume23
Issue number6
StatePublished - 1974

Fingerprint

Diabetic Ketoacidosis
Alloxan
Ketosis
Carbon
Carnitine
Liver
Detergents
Esters
Insulin
Kidney
decanoylcarnitine
octanoylcarnitine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Studies with (+) octanoylcarnitine in experimental diabetic ketoacidosis. / McGarry, J. D.; Foster, D. W.

In: Diabetes, Vol. 23, No. 6, 1974, p. 485-493.

Research output: Contribution to journalArticle

@article{7ff547b178b344aa8766db5fd4a58642,
title = "Studies with (+) octanoylcarnitine in experimental diabetic ketoacidosis",
abstract = "The ability of (+) decanoylcarnitine to inhibit ketogenesis in perfused livers from severely ketotic alloxan diabetic rats and to cause the rapid reversal of ketoacidosis in intact animals was shown not to be the result of a detergent action of this compound, since no such effects were seen when similar experiments were carried out with (-) decanoylcarnitine. Comparison of the hexanoyl, octanoyl and decanoyl esters of (+) carnitine for their antiketogenic capacity in perfused livers from alloxan diabetic rats revealed that the 8 and 10 carbon homologues were equally effective, with the 6 carbon species having less inhibitory properties. When tested in vivo, both in the presence and absence of insulin, the 8 carbon species exhibited the greatest hypoketonemic potential. Further studies with (+) octanoylcarnitine showed that its potent effects in the rat are completely reversible; it is not metabolized in this animal species and is rapidly excreted by the kidneys; it has a far lower hemolytic capacity than (+) decanoylcarnitine; and it is capable of reversing severe ketoacidosis when administered orally, although the doses required using this procedure are much greater than those needed when the agent is given intravenously. It is concluded that (+) acylcarnitines are useful tools for studies of metabolic regulation both in vitro and in vivo. In this regard the compound of choice would seem to be (+) octanoylcarnitine.",
author = "McGarry, {J. D.} and Foster, {D. W.}",
year = "1974",
language = "English (US)",
volume = "23",
pages = "485--493",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Studies with (+) octanoylcarnitine in experimental diabetic ketoacidosis

AU - McGarry, J. D.

AU - Foster, D. W.

PY - 1974

Y1 - 1974

N2 - The ability of (+) decanoylcarnitine to inhibit ketogenesis in perfused livers from severely ketotic alloxan diabetic rats and to cause the rapid reversal of ketoacidosis in intact animals was shown not to be the result of a detergent action of this compound, since no such effects were seen when similar experiments were carried out with (-) decanoylcarnitine. Comparison of the hexanoyl, octanoyl and decanoyl esters of (+) carnitine for their antiketogenic capacity in perfused livers from alloxan diabetic rats revealed that the 8 and 10 carbon homologues were equally effective, with the 6 carbon species having less inhibitory properties. When tested in vivo, both in the presence and absence of insulin, the 8 carbon species exhibited the greatest hypoketonemic potential. Further studies with (+) octanoylcarnitine showed that its potent effects in the rat are completely reversible; it is not metabolized in this animal species and is rapidly excreted by the kidneys; it has a far lower hemolytic capacity than (+) decanoylcarnitine; and it is capable of reversing severe ketoacidosis when administered orally, although the doses required using this procedure are much greater than those needed when the agent is given intravenously. It is concluded that (+) acylcarnitines are useful tools for studies of metabolic regulation both in vitro and in vivo. In this regard the compound of choice would seem to be (+) octanoylcarnitine.

AB - The ability of (+) decanoylcarnitine to inhibit ketogenesis in perfused livers from severely ketotic alloxan diabetic rats and to cause the rapid reversal of ketoacidosis in intact animals was shown not to be the result of a detergent action of this compound, since no such effects were seen when similar experiments were carried out with (-) decanoylcarnitine. Comparison of the hexanoyl, octanoyl and decanoyl esters of (+) carnitine for their antiketogenic capacity in perfused livers from alloxan diabetic rats revealed that the 8 and 10 carbon homologues were equally effective, with the 6 carbon species having less inhibitory properties. When tested in vivo, both in the presence and absence of insulin, the 8 carbon species exhibited the greatest hypoketonemic potential. Further studies with (+) octanoylcarnitine showed that its potent effects in the rat are completely reversible; it is not metabolized in this animal species and is rapidly excreted by the kidneys; it has a far lower hemolytic capacity than (+) decanoylcarnitine; and it is capable of reversing severe ketoacidosis when administered orally, although the doses required using this procedure are much greater than those needed when the agent is given intravenously. It is concluded that (+) acylcarnitines are useful tools for studies of metabolic regulation both in vitro and in vivo. In this regard the compound of choice would seem to be (+) octanoylcarnitine.

UR - http://www.scopus.com/inward/record.url?scp=0016136469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016136469&partnerID=8YFLogxK

M3 - Article

C2 - 4209725

AN - SCOPUS:0016136469

VL - 23

SP - 485

EP - 493

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -